Crinetics Pharmaceuticals, Inc. (CRNX)
44.08
-3.53
(-7.41%)
USD |
NASDAQ |
Feb 12, 16:00
44.08
0.00 (0.00%)
After-Hours: 20:00
Crinetics Pharmaceuticals Cash from Investing (Quarterly) : 164.81M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Madrigal Pharmaceuticals, Inc. | -207.00M |
| GT Biopharma, Inc. | 0.00 |
| Axsome Therapeutics, Inc. | -0.058M |
| Sutro Biopharma, Inc. | 39.99M |
| Gossamer Bio, Inc. | 17.01M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -110.72M |
| Cash from Financing (Quarterly) | 3.084M |
| Free Cash Flow | -356.03M |
| Free Cash Flow Per Share (Quarterly) | -1.184 |
| Free Cash Flow to Equity (Quarterly) | -110.79M |
| Free Cash Flow to Firm (Quarterly) | -111.58M |
| Free Cash Flow Yield | -8.67% |